Rising to the challenge of male hormonal contraception

Despite decades of research, and surveys showing that the majority of men are willing to try it, a reversible male hormonal contraceptive (MHC) has not yet reached the market. There have been many scientific and regulatory barriers to development but recent advances indicate that MHC is at last a realistic prospect.

Source: Prescriber - May 31, 2017 Category: Primary Care Authors: Mark Greener Tags: Research Source Type: research